Stephen Lin
Private Equity Investor bei LAV Management Co., Ltd.
Profil
Stephen Lin, is a Partner with Lilly Asia Ventures (LAV).
Prior to joining LAV, he most recently worked as BD at GlaxoSmithKline (Great China), covering M&A and product licensing.
Prior to that, he managed the marketing of a core product at Merck Serono (China).
In Sanjiu Medical & Pharmaceutical, he set up and headed the Strategic Development Department.
Stephen holds Master of Science in Medicinal Chemistry and Bachelor in Pharmaceutical Chemistry, both from China Pharmaceutical University, and an M.B.A.
degree from China Europe International Business School.
He is also a Licensed Pharmacist in China.
Aktive Positionen von Stephen Lin
Unternehmen | Position | Beginn |
---|---|---|
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Private Equity Investor | - |
GlaxoSmithKline Biologicals (Shenzhen) Co., Ltd. | Corporate Officer/Principal | - |
Ausbildung von Stephen Lin
China Pharmaceutical University | Undergraduate Degree |
China Europe International Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Finance |
GlaxoSmithKline Biologicals (Shenzhen) Co., Ltd. |